AstraZeneca

Our global headquarters moved to Cambridge in May 2016.

Since then, we have delivered over 130 collaborations with our academic, healthcare and research partners to make life-changing discoveries.   

For example, our drug discovery scientists are working with Microsoft to use a cloud-based simulation tool that brings alive the millions of potential changes that make cancer cells multiply uncontrollably, to better understand the disease.

Similarly, scientists from MedImmune and Cancer Research UK are working together to discover and develop novel biologics to treat cancer. Together they are working on a novel target associated with leukaemia and recently started an exciting project looking at the best drug combinations to treat pancreatic cancer.

And a novel agreement is also in place that will give researchers from the University of Cambridge access to key compounds from our drugs pipeline.

Once completed, more than 2,000 AstraZeneca and MedImmune R&D science jobs will be on the CBC site, delivering more knowledge sharing, skills and expertise – and ultimately for pushing the boundaries of science.

Visit website